About Acurian
Acurian is a Healthcare company based in Horsham (United States) founded in 1998, and was acquired by PPD in August 2013. Patient enrollment and retention solutions for clinical trials are offered. Acurian has raised $27 million across 1 funding round from investors including Merck, J P Morgan and PPD. Acurian offers products and services including Patient Recruitment and Integrated Network. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is Global AES. Its competitors include Elligo, Velocity Clinical Research and CenExel; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 1998 and based in Horsham, United States, Acurian operates as a subsidiary of PPD within the clinical research sector. Services focus on patient enrollment and retention for trials, utilizing a database of over 100 million opted-in individuals alongside various recruitment methods. Customized plans are developed to target specific therapeutic areas, supporting faster trial timelines and results-based pricing models.
- Headquarters Horsham, United States
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website acurian.com
- Social LinkedIn X
- Acquired by PPD (Aug 2013)
- Legal Name Global Aes
Products & Services of Acurian
Acurian offers a comprehensive portfolio of products and services, including Patient Recruitment and Integrated Network.
Data-driven strategy for recruiting patients in clinical trials
Manages sites and patients for efficient trial performance
Funding Insights of Acurian
Acurian has successfully raised a total of $27M through 1 strategic funding round. The most recent funding activity was a Series B round of $27 million completed in March 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27M
- Total Rounds 1
- Last Round Series B — $27M
- First Round $27M
(Mar 2001)
- Investors Count 4
All 1 funding rounds of Acurian with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2001 | $27M | Series B | – | – |
5 investors in total: 5 institutional.
Investors in Acurian
Acurian has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Merck, J P Morgan and PPD.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment strategies are provided across diverse asset classes and markets. | 1965 | cdpq.com | Quebec City, Canada | |
| proquestvc.com | ||||
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | merck.com | Kenilworth, United Kingdom | |
Comprehensive financial services are provided to corporations and individuals. | 1799 | jpmorgan.com | New York, United States | |
CRO providing diversified clinical development services | 1985 | ppd.com | Wilmington, United States |
Investor details for Acurian
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Acurian
3 dated milestones of Acurian across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Acurian is founded.
- Funding First funding round of $27.0M.
- Exit Acquired by PPD.
Competitors of Acurian
Acurian has 3 listed competitors in our database, 1 of them funded. They include Elligo, Velocity Clinical Research and CenExel.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| elligohealthresearch.com | 2016 | Austin, United States | $176.48M | 280 | Patient recruitment and site activation services are provided by Elligo. | |
| velocityclinical.com | 2017 | Durham, United States | Provider of site management and patient recruitment services | |||
| cenexelresearch.com | 2019 | Salt Lake, United States | 451 | Research site management and patient recruitment services are provided. |
Detailed competitors of Acurian
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Acurian
Websites that share an audience with Acurian (acurian.com).
- Unique visitors2.1K
per month
- Global rank#3,255,081
among all websites
- Category rank#4,276
Health · Biotechnology and Pharmaceuticals
- Bounce rate63%
- Pages per visit2.4
- Average visit1 min 14 sec
- DevicesDesktop 30% · Mobile 70%
Websites whose visitors overlap most with Acurian. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| centerwatch.com | 100% | 158.2K | #254,725 | View details | |
| trialx.com | 99% | 341.2K | #170,192 | View details | |
| emergingmed.com | 95% | 2.7K | #3,248,647 | View details | |
cancertrialshelp.org | cancertrialshelp.org | 91% | – | ||
scopesummit.com | scopesummit.com | 83% | #754,933 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 25 similar websites and full traffic analytics for Acurian
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 25 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Acurian (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Acurian
Complete news archive for Acurian
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Acurian
Acurian was founded in 1998 and raised its 1st funding round 3 years after it was founded.
Acurian is headquartered in Horsham, United States. It is registered at Horsham, Pennsylvania, United States.
Acurian is a funded company, having raised a total of $27M across 1 funding round to date. The company's 1st funding round was a Series B of $27M, raised on Mar 2001.
Founded in 1998 and based in Horsham, United States, Acurian operates as a subsidiary of PPD within the clinical research sector. Services focus on patient enrollment and retention for trials, utilizing a database of over 100 million opted-in individuals alongside various recruitment methods. Customized plans are developed to target specific therapeutic areas, supporting faster trial timelines and results-based pricing models.
Acurian's top competitors include Velocity Clinical Research, Elligo and CenExel.
Acurian offers Patient Recruitment and Integrated Network.
Acurian has 5 investors. Key investors include Merck, J P Morgan, PPD, Caisse de depot et placement du Quebec, and ProQuest Investments.
Acurian operates through Global Aes.
Yes. Acurian was acquired by PPD in August 2013.